Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Amand F Schmidt

Showing results (41-50 of 60) with videos related to

Pageof 6
Sort By:
Communications Medicine|January 20, 2023
Biomedical consequences of elevated cholesterol-containing lipoproteins and apolipoproteins on cardiovascular and non-cardiovascular outcomesAmand F Schmidt, Roshni Joshi, Maria Gordillo-Marañón, et al.
British Journal of Clinical Pharmacology|March 22, 2020
Association between 8 P-glycoprotein (MDR1/ABCB1) gene polymorphisms and antipsychotic drug-induced hyperprolactinaemiaLisanne M Geers, Ivan V Pozhidaev, Svetlana A Ivanova, et al.
Frontiers in Cardiovascular Medicine|May 2, 2022
Unravelling the Difference Between Men and Women in Post-CABG SurvivalAmand F Schmidt, Saskia Haitjema, Ulrik Sartipy, et al.
Nature Communications|October 22, 2021
Validation of lipid-related therapeutic targets for coronary heart disease prevention using human geneticsMaría Gordillo-Marañón, Magdalena Zwierzyna, Pimphen Charoen, et al.
Nature Communications|September 25, 2021
Cholesteryl ester transfer protein (CETP) as a drug target for cardiovascular diseaseAmand F Schmidt, Nicholas B Hunt, Maria Gordillo-Marañón, et al.
Journal of the American College of Cardiology|May 20, 2023
Individualized Family Screening for Arrhythmogenic Right Ventricular CardiomyopathySteven A Muller, Alessio Gasperetti, Laurens P Bosman, et al.
International Journal of Molecular Sciences|February 25, 2023
Untargeted Metabolomics Identifies Potential Hypertrophic Cardiomyopathy Biomarkers in Carriers of <i>MYBPC3</i> Founder VariantsMark Jansen, Maike Schuldt, Beau O van Driel, et al.
Science Advances|May 1, 2023
Druggable proteins influencing cardiac structure and function: Implications for heart failure therapies and cancer cardiotoxicityAmand F Schmidt, Mimount Bourfiss, Abdulrahman Alasiri, et al.
JACC. Heart Failure|August 11, 2023
Penetrance and Prognosis of MYH7 Variant-Associated Cardiomyopathies: Results From a Dutch Multicenter Cohort StudyMark Jansen, Remco de Brouwer, Fahima Hassanzada, et al.
Circulation. Genomic and Precision Medicine|December 17, 2024
Recreational and Occupational Physical Activity and Risk of Adverse Events in Truncating <i>MYBPC3</i> Founder Variant CarriersFahima Hassanzada, Mark Jansen, Freyja H M van Lint, et al.
Pageof 6

Showing results (41-50 of 60) with videos related to

Sort By:
Pageof 6
Communications Medicine|January 20, 2023
Biomedical consequences of elevated cholesterol-containing lipoproteins and apolipoproteins on cardiovascular and non-cardiovascular outcomesAmand F Schmidt, Roshni Joshi, Maria Gordillo-Marañón, et al.
British Journal of Clinical Pharmacology|March 22, 2020
Association between 8 P-glycoprotein (MDR1/ABCB1) gene polymorphisms and antipsychotic drug-induced hyperprolactinaemiaLisanne M Geers, Ivan V Pozhidaev, Svetlana A Ivanova, et al.
Frontiers in Cardiovascular Medicine|May 2, 2022
Unravelling the Difference Between Men and Women in Post-CABG SurvivalAmand F Schmidt, Saskia Haitjema, Ulrik Sartipy, et al.
Nature Communications|October 22, 2021
Validation of lipid-related therapeutic targets for coronary heart disease prevention using human geneticsMaría Gordillo-Marañón, Magdalena Zwierzyna, Pimphen Charoen, et al.
Nature Communications|September 25, 2021
Cholesteryl ester transfer protein (CETP) as a drug target for cardiovascular diseaseAmand F Schmidt, Nicholas B Hunt, Maria Gordillo-Marañón, et al.
Journal of the American College of Cardiology|May 20, 2023
Individualized Family Screening for Arrhythmogenic Right Ventricular CardiomyopathySteven A Muller, Alessio Gasperetti, Laurens P Bosman, et al.
International Journal of Molecular Sciences|February 25, 2023
Untargeted Metabolomics Identifies Potential Hypertrophic Cardiomyopathy Biomarkers in Carriers of <i>MYBPC3</i> Founder VariantsMark Jansen, Maike Schuldt, Beau O van Driel, et al.
Science Advances|May 1, 2023
Druggable proteins influencing cardiac structure and function: Implications for heart failure therapies and cancer cardiotoxicityAmand F Schmidt, Mimount Bourfiss, Abdulrahman Alasiri, et al.
JACC. Heart Failure|August 11, 2023
Penetrance and Prognosis of MYH7 Variant-Associated Cardiomyopathies: Results From a Dutch Multicenter Cohort StudyMark Jansen, Remco de Brouwer, Fahima Hassanzada, et al.
Circulation. Genomic and Precision Medicine|December 17, 2024
Recreational and Occupational Physical Activity and Risk of Adverse Events in Truncating <i>MYBPC3</i> Founder Variant CarriersFahima Hassanzada, Mark Jansen, Freyja H M van Lint, et al.
Pageof 6